Chinese General Practice ›› 2022, Vol. 25 ›› Issue (03): 305-311.DOI: 10.12114/j.issn.1007-9572.2021.02.109
Special Issue: 肿瘤最新文章合辑
• Article • Previous Articles Next Articles
Predictive Value of Combined Use of Ultrasonographic Indicators for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
1.Department of Ultrasound,the First Affiliated Hospital of Shihezi University School of Medicine,Shihezi 832008,China
2.Department of Pathology,Shihezi University School of Medicine,Shihezi 832008,China
3.NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases,Shihezi 832008,China
*Corresponding author:LI Jun,Associate chief physician,Associate professor;E-mail:1287424798@qq.com
Received:
2021-09-26
Revised:
2021-11-10
Published:
2022-01-20
Online:
2021-12-29
通讯作者:
李军
基金资助:
CLC Number:
ZHANG Xiaomei, KANG Yanfei, SANG Tian, CHENG Jing, LI Qiaoli, CAO Yuwen, MA Jinmei, SHI Linan, LI Wenxiao, LI Jun.
Predictive Value of Combined Use of Ultrasonographic Indicators for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma [J]. Chinese General Practice, 2022, 25(03): 305-311.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.109
影响因素 | 例数 | 发生颈部CLNM | χ2值 | P值 | 影响因素 | 例数 | 发生颈部CLNM | χ2值 | P值 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
性别 | 7.489 | 0.006 | 边界 | 1.463 | 0.226 | ||||||
男 | 97 | 46(47.42) | 清晰 | 272 | 91(33.46) | ||||||
女 | 349 | 113(32.38) | 不清晰 | 174 | 68(39.08) | ||||||
年龄(岁) | 20.683 | <0.001 | 边缘 | 4.447 | 0.035 | ||||||
≥45 | 324 | 95(29.32) | 光整 | 137 | 39(28.47) | ||||||
<45 | 122 | 64(52.46) | 不光整 | 309 | 120(38.83) | ||||||
结节直径(mm) | 22.524 | <0.001 | 微钙化 | 6.152 | 0.013 | ||||||
>10 | 165 | 82(49.70) | 有 | 328 | 128(39.02) | ||||||
≤10 | 281 | 77(27.40) | 无 | 118 | 31(26.27) | ||||||
结节数目 | 1.384 | 0.239 | 纵横比 | 10.556 | 0.001 | ||||||
单发 | 299 | 101(33.78) | ≥1 | 220 | 62(28.18) | ||||||
多发 | 147 | 58(39.45) | <1 | 226 | 97(42.92) | ||||||
内部成分 | 0a | 1.000 | 后方回声衰减 | 0.210 | 0.647 | ||||||
囊实性 | 9 | 3(33.33) | 有 | 135 | 46(34.07) | ||||||
实性 | 437 | 156(35.70) | 无 | 311 | 113(36.33) | ||||||
内部回声 | 1.139 | 0.286 | 被膜侵犯 | 14.784 | <0.001 | ||||||
低回声 | 417 | 146(35.01) | 有 | 182 | 84(46.15) | ||||||
其他回声 | 29 | 13(44.83) | 无 | 264 | 75(28.41) |
Table 1 Univariate analysis of the influencing factors for central lymph node metastasis in papillary thyroid carcinoma
影响因素 | 例数 | 发生颈部CLNM | χ2值 | P值 | 影响因素 | 例数 | 发生颈部CLNM | χ2值 | P值 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
性别 | 7.489 | 0.006 | 边界 | 1.463 | 0.226 | ||||||
男 | 97 | 46(47.42) | 清晰 | 272 | 91(33.46) | ||||||
女 | 349 | 113(32.38) | 不清晰 | 174 | 68(39.08) | ||||||
年龄(岁) | 20.683 | <0.001 | 边缘 | 4.447 | 0.035 | ||||||
≥45 | 324 | 95(29.32) | 光整 | 137 | 39(28.47) | ||||||
<45 | 122 | 64(52.46) | 不光整 | 309 | 120(38.83) | ||||||
结节直径(mm) | 22.524 | <0.001 | 微钙化 | 6.152 | 0.013 | ||||||
>10 | 165 | 82(49.70) | 有 | 328 | 128(39.02) | ||||||
≤10 | 281 | 77(27.40) | 无 | 118 | 31(26.27) | ||||||
结节数目 | 1.384 | 0.239 | 纵横比 | 10.556 | 0.001 | ||||||
单发 | 299 | 101(33.78) | ≥1 | 220 | 62(28.18) | ||||||
多发 | 147 | 58(39.45) | <1 | 226 | 97(42.92) | ||||||
内部成分 | 0a | 1.000 | 后方回声衰减 | 0.210 | 0.647 | ||||||
囊实性 | 9 | 3(33.33) | 有 | 135 | 46(34.07) | ||||||
实性 | 437 | 156(35.70) | 无 | 311 | 113(36.33) | ||||||
内部回声 | 1.139 | 0.286 | 被膜侵犯 | 14.784 | <0.001 | ||||||
低回声 | 417 | 146(35.01) | 有 | 182 | 84(46.15) | ||||||
其他回声 | 29 | 13(44.83) | 无 | 264 | 75(28.41) |
因素 | 赋值 |
---|---|
发生颈部CLNM | 是=1,否=0 |
性别 | 男=1,女=0 |
年龄 | <45岁=1,≥45岁=0 |
结节直径 | >10 mm=1,≤10 mm=0 |
边缘 | 不光整=1,光整=0 |
微钙化 | 有=1,无=0 |
纵横比 | ≥1=1,<1=0 |
被膜侵犯 | 有=1,无=0 |
Table 2 Value assignment of the influencing factors for central lymph node metastasis in papillary thyroid carcinoma by binary Logistic regression analysis
因素 | 赋值 |
---|---|
发生颈部CLNM | 是=1,否=0 |
性别 | 男=1,女=0 |
年龄 | <45岁=1,≥45岁=0 |
结节直径 | >10 mm=1,≤10 mm=0 |
边缘 | 不光整=1,光整=0 |
微钙化 | 有=1,无=0 |
纵横比 | ≥1=1,<1=0 |
被膜侵犯 | 有=1,无=0 |
影响因素 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
常数 | -1.627 | 0.191 | 72.754 | <0.001 | 0.197 | - |
男性 | 0.546 | 0.249 | 4.802 | 0.028 | 1.727 | (1.059,2.816) |
年龄(<45岁) | 0.989 | 0.226 | 19.211 | <0.001 | 2.690 | (1.728,4.187) |
结节直径>10 mm | 0.869 | 0.222 | 15.344 | <0.001 | 2.385 | (1.544,3.684) |
被膜侵犯 | 0.572 | 0.219 | 6.811 | 0.009 | 1.773 | (1.153,2.724) |
Table 3 Binary Logistic regression analysis of influencing factors for central lymph node metastasis in papillary thyroid carcinoma
影响因素 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
常数 | -1.627 | 0.191 | 72.754 | <0.001 | 0.197 | - |
男性 | 0.546 | 0.249 | 4.802 | 0.028 | 1.727 | (1.059,2.816) |
年龄(<45岁) | 0.989 | 0.226 | 19.211 | <0.001 | 2.690 | (1.728,4.187) |
结节直径>10 mm | 0.869 | 0.222 | 15.344 | <0.001 | 2.385 | (1.544,3.684) |
被膜侵犯 | 0.572 | 0.219 | 6.811 | 0.009 | 1.773 | (1.153,2.724) |
Figure 3 ROC curves of sex,age and ultrasonographic indicators of thyroid nodule diameter and capsular invasion in predicting central lymph node metastasis in papillary thyroid carcinoma alone and in combination
指标 | 灵敏度(%) | 特异度(%) | AUC(95%CI) |
---|---|---|---|
联合指标 | 67.92 | 61.67 | 0.695(0.650,0.738) |
性别 | 28.93 | 82.23 | 0.556(0.508,0.603) |
年龄 | 42.77 | 77.70 | 0.602(0.555,0.648) |
结节直径 | 51.57 | 71.08 | 0.613(0.566,0.659) |
被膜侵犯 | 52.83 | 65.85 | 0.593(0.546,0.639) |
Table 4 The sensitivity,specificity and AUC of sex,age,ultrasonographic indicators of thyroid nodule diameter and capsular invasion in predicting central lymph node metastasis in papillary thyroid carcinoma alone and in combination
指标 | 灵敏度(%) | 特异度(%) | AUC(95%CI) |
---|---|---|---|
联合指标 | 67.92 | 61.67 | 0.695(0.650,0.738) |
性别 | 28.93 | 82.23 | 0.556(0.508,0.603) |
年龄 | 42.77 | 77.70 | 0.602(0.555,0.648) |
结节直径 | 51.57 | 71.08 | 0.613(0.566,0.659) |
被膜侵犯 | 52.83 | 65.85 | 0.593(0.546,0.639) |
[1] | International Agency for Research on Cancer[EB/OL]. [2021-09-02]. . |
[2] | SHENG L, SHI J, HAN B,et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma[J]. Am J Surg,2020,220(2):334-340. DOI:10.1016/j.amjsurg.2019.11.032. |
[3] | ZHANG Q, WANG Z, MENG X,et al. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC):a retrospective analysis of 1304 cases[J]. Asian J Surg,2019,42(4):571-576. DOI:10.1016/j.asjsur.2018.08.013. |
[4] | 曾静,杨礼,于结. 老年甲状腺癌结节超声特征与颈部淋巴结转移的相关性[J]. 中国老年学杂志,2020,40(1):65-68. DOI:10.3969/j.issn.1005-9202.2020.01.022. |
[5] | LIU C X, XIAO C, CHEN J J,et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma:a study of 966 patients[J]. BMC Cancer,2019,19(1):622. DOI:10.1186/s12885-019-5835-6. |
[6] | WU L M, GU H Y, QU X H,et al. The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma:a meta-analysis[J]. Eur J Radiol,2012,81(8):1798-1805. DOI:10.1016/j.ejrad.2011.04.028. |
[7] | AHN B H, KIM J R, JEONG H C,et al. Predictive factors of central lymph node metastasis in papillary thyroid carcinoma[J]. Ann Surg Treat Res,2015,88(2):63-68. DOI:10.4174/astr.2015.88.2.63. |
[8] | 董芬,张彪,单广良. 中国甲状腺癌的流行现状和影响因素[J]. 中国癌症杂志,2016,26(1):47-52. DOI:10.3969/j.issn.1007-3969.2016.01.008. |
[9] | 温泉,罗渝昆. 甲状腺乳头状癌超声声像图表现与颈部淋巴结转移的相关性[J]. 中国医学装备,2018,15(6):67-71. DOI:10.3969/j.issn.1672-8270.2018.06.018. |
[10] | 王晓庆,魏玮,魏玺,等. 甲状腺乳头状癌的超声表现及其与颈部中央区淋巴结转移的关系[J]. 中华肿瘤杂志,2018,40(3):196-200. DOI:10.3760/cma.j.issn.0253-3766.2018.03.007. |
[11] | 孙庆贺,张磊,杨进宝,等. 2073例乳头状甲状腺癌淋巴结转移的因素分析 [J]. 中华外科杂志,2017,55(8):592-598. DOI:10.3760/cma.j.issn.0529-5815.2017.08.008. |
[12] | 彭琛,魏松锋,郑向前,等. 1401例甲状腺微小乳头状癌临床病理特征及中央区淋巴结转移危险因素分析[J]. 中国肿瘤临床,2016,43(3):95-99. DOI:10.3969/j.issn.1000-8179.2016.03.187. |
[13] | WU X, LI B L, ZHENG C J,et al. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma[J]. World J Clin Cases,2020,8(8):1350-1360. DOI:10.12998/wjcc.v8.i8.1350. |
[14] | LIANG J W, LUO Y H, LIANG K,et al. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma:a single center retrospective study[J]. Braz J Otorhinolaryngol,2020. DOI:10.1016/j.bjorl.2020.05.004. |
[15] | ZHENG X Q, PENG C, GAO M,et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma:a study of 1 587 patients[J]. Cancer Biol Med,2019,16(1):121-130. DOI:10.20892/j.issn.2095-3941.2018.0125. |
[16] | WANG X, TAN J, ZHENG W,et al. A retrospective study of the clinical features in papillary thyroid microcarcinoma depending on age[J]. Nucl Med Commun,2018,39(8):713-719. DOI:10.1097/MNM.0000000000000859. |
[17] | NIXON I J, KUK D, WREESMANN V,et al. Defining a valid age cutoff in staging of well-differentiated thyroid cancer[J]. Ann Surg Oncol,2016,23(2):410-415. DOI:10.1245/s10434-015-4762-2. |
[18] | PERRIER N D, BRIERLEY J D, TUTTLE R M. Differentiated and anaplastic thyroid carcinoma:major changes in the American Joint Committee on Cancer eighth edition cancer staging manual[J]. CA Cancer J Clin,2018,68(1):55-63. DOI:10.3322/caac.21439. |
[19] | 常淑娟,杨锦茹,袁娜,等. 甲状腺乳头状癌声像图表现与其颈部淋巴结转移的关系[J]. 中国医学影像技术,2019,35(5):673-676. DOI:10.13929/j.1003-3289.201808194. |
[20] | 卢晓玲,黄鹏飞,刘春蕊,等. 超声特征对甲状腺乳头状癌颈部淋巴结转移的预测价值[J]. 医学研究生学报,2017,30(12):1309-1312. DOI:10.16571/j.cnki.1008-8199.2017.12.017. |
[21] | HE Y, WANG X Y, HU Q,et al. Value of contrast-enhanced ultrasound and acoustic radiation force impulse imaging for the differential diagnosis of benign and malignant thyroid nodules[J]. Front Pharmacol,2018,9:1363. DOI:10.3389/fphar.2018.01363. |
[22] | 吴艳乐,孙锦明,张进军,等. 甲状腺微小乳头状癌临床病理特征及中央区淋巴结转移危险因素分析[J]. 中华耳鼻咽喉头颈外科杂志,2017,52(6):426-429. DOI:10.3760/cma.j.issn.1673-0860.2017.06.006. |
[23] | 曲琪,严继萍,王金萍. 甲状腺乳头状癌超声表现及BRAFV600E基因突变与颈部淋巴结转移的相关性[J]. 实用癌症杂志,2020,35(12):1936-1939. DOI:10.3969/j.issn.1001-5930.2020.12.006. |
[24] | 刘如玉,张波. 美国放射学会甲状腺结节影像报告系统和影像偶发甲状腺结节管理系列白皮书解读[J]. 中国癌症杂志,2018,28(2):88-97. DOI:10.19401/j.cnki.1007-3639.2018.02.002. |
[25] | HAUGEN B R, ALEXANDER E K, BIBLE K C,et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2016,26(1):1-133. DOI:10.1089/thy.2015.0020. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||